Alison Kodjak

Alison Fitzgerald Kodjak is a health policy correspondent on NPR's Science Desk.

Her work focuses on the business and politics of health care and how those forces flow through to the general public. Her stories about drug prices, limits on insurance and changes in Medicare and Medicaid appear on NPR's shows and in the Shots blog.

She joined NPR in September 2015 after a nearly two-decade career in print journalism, where she won several awards—including three George Polk Awards—as an economics, finance, and investigative reporter.

She spent two years at the Center for Public Integrity, leading projects in financial, telecom, and political reporting. Her first project at the Center, "After the Meltdown," was honored with the 2014 Polk Award for business reporting and the Society of Professional Journalists Sigma Delta Chi award.

Her work as both reporter and editor on the foreclosure crisis in Florida, on Warren Buffet's predatory mobile home businesses, and on the telecom industry were honored by several journalism organizations. She was part of the International Consortium of Investigative Journalists team that won the 2015 Polk Award for revealing offshore banking practices.

Prior to joining the Center, Alison spent more than a decade at Bloomberg News, where she wrote about the convergence of politics, government, and economics. She interviewed chairmen of the Federal Reserve and traveled the world with two U.S. Treasury secretaries.

And as part of Bloomberg's investigative team she wrote about the bankruptcy of General Motors Corp. and the 2010 Gulf Oil Spill. She was part of a team at Bloomberg that successfully sued the Federal Reserve to release records of the 2008 bank bailouts, an effort that was honored with the 2009 George Polk Award. Her work on the international food price crisis in 2008 won her the Overseas Press Club's Malcolm Forbes Award.

Fitzgerald Kodjak and co-author Stanley Reed are authors of In Too Deep: BP and the Drilling Race that Took It Down, published in 2011 by John Wiley & Sons.

She's a graduate of Georgetown University and Northwestern University's Medill School of Journalism.

She raises children and chickens in suburban Maryland.

If President Trump decides to cut off payments to insurance companies called for under the Affordable Care Act, it's going to cost him.

Or, more accurately, it's going to cost taxpayers — about $194 billion over 10 years.

The cost is "eye-poppingly large," says Nicholas Bagley, a professor of health law at the University of Michigan. "This single policy could effectively end up costing 20 percent of the entire bill of the ACA."

The Trump administration is giving insurance companies an extra three weeks to decide whether to offer insurance plans through the Affordable Care Act markets, and how much to charge.

The extension comes as insurance companies wait for President Trump to decide whether he will continue to make payments to insurance companies that are called for under the Affordable Care Act but that some Republicans have opposed.

Opioid abuse is a crisis, but is it an emergency?

That's the question gripping Washington after President Trump's Commission on Combating Drug Addiction and the Opioid Crisis recommended that the president declare the epidemic a national emergency.

Ten years ago, Fumiko Chino was the art director at a television production company in Houston, engaged to be married to a young Ph.D. candidate.

Today, she's a radiation oncologist at Duke University, studying the effects of financial strain on cancer patients. And she's a widow.

How she got from there to here is a story about how health care and money are intertwined in ways that doctors and patients don't like to talk about.

In Prince George's County, Md., every first responder carries naloxone, the drug that can reverse an opioid overdose.

"We carry it in our first-in bags," says Bryan Spies, the county's battalion chief in charge of emergency services. "So whenever we arrive at a patient's side, it's in the bag, along with things like glucose, aspirin and oxygen."

Pages